Top-Rated StocksTop-RatedNASDAQ:EXEL Exelixis (EXEL) Insider Trading & Ownership $19.28 +0.27 (+1.42%) (As of 05/31/2023 ET) Add Compare Share Share Today's Range$19.00▼$19.3850-Day Range$18.17▼$20.4852-Week Range$14.87▼$22.47Volume3.43 million shsAverage Volume2.96 million shsMarket Capitalization$6.28 billionP/E Ratio40.17Dividend YieldN/APrice Target$25.33 Insider TradesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Exelixis (NASDAQ:EXEL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.90%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$5.91 M EXEL Insider Buying and Selling by Quarter Get EXEL Insider Trade Alerts Want to know when executives and insiders are buying or selling Exelixis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Exelixis Insider Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails4/5/2023Jeffrey HessekielEVPSell38,930$20.01$778,989.30582,435 3/10/2023Jack L WyszomierskiDirectorSell15,300$16.61$254,133.00317,467 3/1/2023Jeffrey HessekielEVPSell77,860$17.13$1,333,741.80527,716 2/27/2023Dana AftabEVPSell10$17.50$175.00351,472 2/21/2023Alan M GarberDirectorSell40,000$17.49$699,600.0031,417 2/9/2023Carl B FeldbaumDirectorSell40,000$17.78$711,200.0018,701 2/6/2023Patrick J HaleyEVPSell25,000$17.37$434,250.00254,414 12/15/2022Peter LambEVPSell20,000$15.88$317,600.00410,958 11/29/2022George PosteDirectorSell40,000$16.68$667,200.00193,189 9/12/2022Patrick J HaleyEVPSell40,000$17.94$717,600.00261,591 (Data available from 1/1/2013 forward) EXEL Insider Trading Activity - Frequently Asked Questions Who is on Exelixis's Insider Roster? The list of insiders at Exelixis includes Alan M Garber, Carl B Feldbaum, Charles Cohen, Christopher J. Senner, Dana Aftab, George Poste, Gisela Schwab, Jack L Wyszomierski, Jeffrey Hessekiel, Lance Willsey, Patrick J Haley, Peter Lamb, Stelios Papadopoulos, and Vincent T. Marchesi. Learn more on insiders at EXEL. What percentage of Exelixis stock is owned by insiders? 2.90% of Exelixis stock is owned by insiders. Learn more on EXEL's insider holdings. Which Exelixis insiders have been selling company stock? The following insiders have sold EXEL shares in the last 24 months: Alan M Garber ($1,146,921.00), Carl B Feldbaum ($1,063,600.00), Dana Aftab ($175.00), George Poste ($667,200.00), Jack L Wyszomierski ($408,141.00), Jeffrey Hessekiel ($3,146,252.61), Lance Willsey ($786,000.00), Patrick J Haley ($3,090,637.52), Peter Lamb ($6,439,675.00), and Stelios Papadopoulos ($1,653,113.40). How much insider selling is happening at Exelixis? Insiders have sold a total of 1,003,994 Exelixis shares in the last 24 months for a total of $18,910,715.53 sold. More Insider Trading Tools from MarketBeat Related Companies: Halozyme Therapeutics Insider Trades Neurocrine Biosciences Insider Trades Repligen Insider Trades BioCryst Pharmaceuticals Insider Trades CRISPR Therapeutics Insider Trades Vaxcyte Insider Trades Denali Therapeutics Insider Trades Vir Biotechnology Insider Trades Ginkgo Bioworks Insider Trades Krystal Biotech Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 2 Cheap Stocks And 1 Cheap Sector The Insiders Are BuyingTyson Insiders Buy Shares At Multi-Year Low3 High-Yield Banks Insiders Are Buying Insiders Drive Volatility For Keurig Dr PepperInsiders Buy Wag! Group, Sell-Side Buys Too This page (NASDAQ:EXEL) was last updated on 6/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exelixis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.